Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission
Status:
Unknown status
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect and safety of Tripterygium Glycosides in
the treatment of Crohn's disease for induction remission and compare the therapeutic effect
with patients who received mesalazine.